Less Ads, More Data, More Tools Register for FREE

Pin to quick picksM P Evans Regulatory News (MPE)

Share Price Information for M P Evans (MPE)

Share Price is delayed by 15 minutes
Get Live Data
1,592.00    44.00 (2.84%)
Bid:
1,580.00
Ask:
1,586.00
Spread: 6.00 (0.38%)
Market Cap: £827.82m
MPE Live PriceLast checked at - London Stock Exchange

Intraday M P Evans Share Chart

Director/PDMR Shareholding

26 Mar 2026 10:16

RNS Number : 2814Y
M. P. Evans Group PLC
26 March 2026
 

M.P. EVANS GROUP PLC

("Company" or "M.P. Evans")

 

Director/PDMR Shareholding

 

The Company was notified that Tanya Ashton, a non-executive director of the Company, purchased 669 shares of 10p each in the capital of the Company ("Shares") on 24 March 2026.

 

Following the purchase, Tanya Ashton now has an interest in 669 Shares (0.001%).

 

The notification below, provided in accordance with the requirements of the UK Market Abuse Regulation, provides further details.

 

1

Details of the persons discharging managerial responsibilities / person closely associated

a)

Name

Tanya Ashton

2

Reason for the notification

a)

Position/status

Non-executive director

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

M.P. Evans Group PLC

b)

LEI

2138003IBXJUCR4SZG26

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Share

Identification code

ISIN: GB0007538100

b)

Nature of the transaction

Purchase of 10p shares in the capital of M.P. Evans Group PLC

c)

Price(s) and volume(s)

Purchase price per share

Volumes

 1492.92 pence

669

d)

Aggregated information

 

Volume: 669

Price: £9,987.63

e)

Date of the transaction

24 March 2026

f)

Place of the transaction

London Stock Exchange (XLON); AIM

 

 

 

 

 

 

 

Enquiries:

 

M.P. Evans Group PLC

Tel: +44 (0) 1892 516333

Peter Hadsley-Chaplin, chairman

Matthew Coulson, chief executive

Luke Shaw, chief financial officer

Cavendish Capital Markets (Nomad and joint broker)

Tel: +44 (0) 20 7220 0500

Matt Goode, George Lawson (Corporate finance)

Harriet Ward (ECM)

Canaccord Genuity Limited (Joint broker)

Tel: +44 (0) 20 7523 4500

Henry Fitzgerald-O'Connor, George Grainger

Alma Strategic Communications (Financial PR)

Tel: +44 (0)20 3405 0205

Rebecca Sanders-Hewett, Josh Royston, David Ison

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSEDFSMEMSEFD
Date   Source Headline
18th Dec 20257:00 amRNSDirector/PDMR Shareholding
16th Dec 20257:00 amRNSDirector/PDMR Shareholding
11th Dec 202512:58 pmRNSPublication of 2024 ESG report
2nd Dec 20251:14 pmRNSCompany update
1st Dec 20257:00 amRNSAppointment of joint broker
10th Nov 20257:00 amRNSStrong pricing during second half of 2025
28th Oct 20255:33 pmRNSHolding(s) in Company
22nd Sep 20253:26 pmRNSAIM Rule 20
15th Sep 20257:00 amRNSHalf-year Report
27th Aug 20257:00 amRNSNotice of interim results & investor presentation
29th Jul 20257:00 amRNSPublication of TCFD report
24th Jul 20257:00 amRNS2025 H1 crop and production
14th Jul 202510:07 amRNSAcquisition
7th Jul 20254:54 pmRNSDirector/PDMR Shareholding
30th Jun 20254:30 pmRNSTotal Voting Rights
25th Jun 202511:18 amRNSIssue of Equity
18th Jun 20257:00 amRNSShare buyback programme
13th Jun 20251:45 pmRNSResult of AGM
13th Jun 20257:00 amRNSAGM Statement
12th Jun 20254:50 pmRNSAppointment to board roles
5th Jun 20257:00 amRNSAGM update
14th May 20257:00 amRNSDirectorate Change
22nd Apr 20255:33 pmRNSDirector/PDMR Shareholding
16th Apr 202511:00 amRNSAcquisition
31st Mar 20254:02 pmRNSPosting of Annual Report
25th Mar 20257:00 amRNSFinal Results
21st Mar 20257:00 amRNSDirector retirement
5th Mar 20257:00 amRNSNotice of Results and investor presentation
20th Jan 20253:05 pmRNSDirector/PDMR Shareholding
20th Jan 20257:00 amRNSCrop and production
2nd Jan 202511:31 amRNSDirector/PDMR Shareholding
2nd Jan 20257:00 amRNSHolding(s) in Company
31st Dec 20247:00 amRNSTransaction in Own Shares
24th Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20247:00 amRNSDirector/PDMR Shareholding
29th Nov 20244:35 pmRNSTotal Voting Rights
15th Nov 20247:00 amRNSStrong CPO pricing during second half of 2024
13th Nov 20247:00 amRNSDirector/PDMR Shareholding
7th Nov 20247:00 amRNSDirector/PDMR Shareholding
5th Nov 20249:15 amRNSDirector/PDMR Shareholding
31st Oct 20245:35 pmRNSTotal Voting Rights
30th Oct 20247:00 amRNSTransaction in Own Shares
30th Sep 202411:25 amRNSTotal Voting Rights
27th Sep 20241:45 pmRNSIndonesian Export Levy Update
26th Sep 20242:30 pmRNSHolding(s) in Company
26th Sep 20242:22 pmRNSDirector/PDMR Shareholding
16th Sep 20248:05 amRNSExtension of share buyback
16th Sep 20247:00 amRNSHalf-year Report
11th Sep 20247:00 amRNSTransaction in Own Shares
9th Sep 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.